PIERIS PHARMACEUTICALS, INC. (PIRS) Net Income (Loss) Attributable to Parent USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2024.
  • Pieris Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$4.89 M, a 62.9% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$16.3 M, a 60.7% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$24.5 M, a 26.2% increase from 2022.
  • Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.3 M, a 27.2% increase from 2021.
  • Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.7 M, a 22.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$16.3 M -$4.89 M +$8.29 M +62.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$24.5 M -$4.58 M +$3.52 M +43.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$28.1 M -$10.8 M -$1.02 M -10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$27 M $3.98 M +$14.3 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$41.4 M -$13.2 M -$8.08 M -158% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$33.3 M -$8.1 M +$1.43 M +15% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$34.7 M -$9.74 M +$6.8 M +41.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$41.5 M -$10.3 M +$5.16 M +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$46.7 M -$5.1 M -$929 K -22.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$45.7 M -$9.53 M +$4.87 M +33.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$50.6 M -$16.5 M -$2.25 M -15.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$48.4 M -$15.5 M -$10.5 M -213% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$37.8 M -$4.17 M -$575 K -16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$37.2 M -$14.4 M -$13.6 M -1768% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$23.6 M -$14.3 M -$11.7 M -451% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$11.9 M -$4.95 M +$6.81 M +57.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$18.7 M -$3.6 M +$6.75 M +65.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$25.5 M -$771 K +$10.9 M +93.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$36.4 M -$2.59 M +$3.56 M +57.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$39.9 M -$11.8 M -$11.6 M -5692% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$28.4 M -$10.3 M -$1.63 M -18.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$26.8 M -$11.7 M -$19.2 M -256% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$7.58 M -$6.15 M +$906 K +12.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$8.49 M -$203 K +$9.88 M +98% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$18.4 M -$8.71 M -$720 K -9.01% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$17.6 M $7.49 M +$14 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$31.7 M -$7.06 M -$863 K -13.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$30.8 M -$10.1 M -$4.2 M -71.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$26.6 M -$7.99 M -$3.83 M -92.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$22.8 M -$6.56 M -$3.66 M -126% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$19.1 M -$6.2 M -$2.27 M -58% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$16.9 M -$5.88 M -$2.35 M -66.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$14.5 M -$4.16 M -$456 K -12.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$14.1 M -$2.9 M +$1.26 M +30.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$15.3 M -$3.92 M -$1.9 M -94% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$13.4 M -$3.53 M -$648 K -22.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$12.8 M -$3.7 M -$2.92 M -375% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$9.85 M -$4.17 M -$4.16 M -189448% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$5.69 M -$2.02 M -$2.02 M -34995% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$3.67 M -$2.88 M Apr 4, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$780 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$2.2 K* Oct 1, 2013 Dec 31, 2013 10-Q 2014-05-14
Q3 2013 -$5.76 K* Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.